Not Yet Recruiting
Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy
NCT07151326
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Chang-Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan
- Taichung Veterans General Hospital Taichung, Taiwan
- China Medical University Hospital Taichung, Taiwan
- National Cheng-Kung University Hospital Tainan, Taiwan